成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

上海一飛生物科技有限公司 公司信息

公司名稱: 上海一飛生物科技有限公司
電話: 021-65675885
電子郵件:customer_service@efebio.com
國籍:中國
網址: http://www.efebio.com
產品總數(shù):11974

公司提供產品列表

PDK1-IN-RS2 PDK1-IN-RS2 1643958-89-7
Eptinezumab 依普奈珠單抗 1644539-04-7
TDRL-551 化合物 T28935 1644626-43-6
HTL14242 Benzonitrile, 3-chloro-5-[6-(5-fluoro-2-pyridinyl)-4-pyrimidinyl]- 1644645-32-8
DA-6886 1645260-76-9 1645260-76-9
Tomuzotuximab Tomuzotuximab 1646321-00-7
FD-IN-1 FD-IN-1 1646682-14-5
BTA-9881 化合物 T26914 1646857-24-0
(R)-AZD 9639 化合物 (R)-AZD 9639 1646857-28-4
Gimsilumab 瑾司魯單抗 1648796-29-5
Fremanezumab 瑞瑪奈珠單抗 1655501-53-3
NDB NDB 1660153-08-1
CRT-0105950 CRT-0105950 (CRT0105950) 1661845-86-8
Parthenosin b-D-Glucopyranosiduronic acid,2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-1-benzopyran-3-yl, butyl ester 166196-16-3
Flotetuzumab Flotetuzumab 1664355-28-5
Timigutuzumab Timigutuzumab 1665274-14-5
AGN 192870 化合物 AGN 192870 166977-57-7
Enrasentan 1H-Indene-2-carboxylicacid,1-(1,3-benzodioxol-5-yl)-2,3-dihydro-3-[2-(2-hydroxyethoxy)-4-methoxyphenyl]-5-propoxy-,(1S,2R,3S)- 167256-08-8
Relatlimab Relatlimab 1673516-98-7
TGP-377/421 化合物 TGP-377/421 16752-89-9
Fluoroethylnormemantine FLUOROETHYLNORMEMANTINE 1639210-26-6
Lupartumab Lupartumab 1640971-88-5
TASP0390325 2-(3-Chloro-4-fluorophenyl)-N-(1-methylethyl)-6-[3-(4-morpholinyl)propoxy]-4-oxo-pyrido[2,3-d]pyrimidine-3(4H)-acetamide hydrochloride 1642187-96-9
Leramistat HMC-C-01-A|||MBS2320 1642602-54-7
Zilovertamab 澤羅妥單抗 1643432-38-5
PW0464 PW0464 1643462-93-4
SLMP53-1 化合物 SLMP53-1 1643469-17-3
Elsubrutinib ELSUBRUTINIB 1643570-24-4
Frovocimab Frovocimab 1643672-70-1
ZEN-3694 ZEN 3694 1643947-30-1
Talastine 他拉斯汀 16188-61-7
Honokiol DCA Acetic acid, 2,2-dichloro-, 2'-[(2,2-dichloroacetyl)oxy]-3,5'-di-2-propen-1-yl[1,1'-biphenyl]-4-yl ester 1620160-42-0
L-372662 化合物 T32497 162045-26-3
3-(Piperidin-4-yl)benzo[d]oxazol-2(3H)-one hydrochloride 3-(哌啶-4-基)苯并[D]噁唑-2(3H)-酮鹽酸鹽 162045-54-7
GNE-8505 GNE-8505 1620573-48-9
TL4-12 化合物 T26280 1620820-12-3
Nav1.8-IN-4 2-(4-氟-2-甲基苯氧基)-N-(2-氧代-1,2-二氫吡啶-4-基)-4-(三氟甲基)苯甲酰胺 1620846-16-3
GPR81 agonist 1 化合物 GPR81 AGONIST 1 1620992-67-7
UCM-13207 化合物 UCM-13207 1621536-10-4
Clivatuzumab 克利妥珠單抗 1622075-09-5
Selicrelumab 塞魯單抗 1622140-49-1
Laprituximab Laprituximab 1622327-38-1
Naratuximab 那妥昔單抗 1622327-39-2
Zectivimod ZECTIVIMOD 1623066-63-6
Glycopyrronium tosylate 格隆銨甲苯磺酸鹽 1624259-25-1
Isolupalbigenin ISOLUPALBIGENIN 162616-70-8
ABI-1968 1626364-18-8 1626364-18-8
(Rac)-Telinavir 化合物 (RAC)-TELINAVIR 162679-88-1
AC 7739 化合物 AC 7739 162705-22-8
JG-231 JG-231 1627126-59-3
Rivabazumab Rivabazumab 1627519-84-9
TAK-020 化合物TAK-020 1627603-21-7
Nerelimomab Nerelimomab [usan:inn] 162774-06-3
FGFR4-IN-5 FGFR4-IN-5 1628793-01-0
GBT1118 化合物 GBT1118 1628799-51-8
Vobarilizumab Vobarilizumab 1628814-88-9
Itacnosertib N4-([2,2-bipyridin]-3-yl)-N2-(3-methoxy-4-(4-methylpiperazin-1-yl)phenyl)pyrimidine-2,4-diamine 1628870-27-8
KZR-504 KZR-504 1629052-78-3
Ibiglustat succinate IBIGLUSTAT SUCCINATE 1629063-80-4
Suptavumab Suptavumab 1629615-23-1
ALDH2 modulator 1 ALDH2調節(jié)劑1 1629615-99-1
Suvratoxumab Suvratoxumab 1629620-18-3
Ladiratuzumab LADIRATUZUMAB (ANTI-SLC39A6) 1629760-28-6
Dalzanemdor 化合物 DALZANEMDOR 1629853-48-0
BDBM50597431 化合物BDBM50597431 1629853-49-1
(R)-DNMDP (R)-DNMDP 1630760-60-9
URAT1 inhibitor 7 URAT1 INHIBITOR 7 1632002-28-8
Dapson-13C12 氨苯砜(13C12) 1632119-29-9
Ranevetmab Ranevetmab 1632282-27-9
DHODH-IN-17 化合物 DHODH-IN-17 16344-26-6
Talviraline HBY 097 163451-80-7
Aprutumab 阿普盧妥單抗 1634620-63-5
Tavolixizumab Tavolimab 1635395-25-3
Ralaniten triacetate RALANITEN TRIACETATE 1637573-04-6
Cipepofol 化合物 T32105 1637741-58-2
GS-626510 GS-626510 1637770-13-8
DI-82 DI-82 1638148-50-1
Osimertinib-d6 奧希替尼雜質28 1638281-44-3
Navicixizumab Navicixizumab 1638338-43-8
VU0453379 VU0453379 1638646-27-1
Vonlerolizumab Vonlerolizumab 1638935-72-4
MAO-B-IN-8 化合物 MAO-B-IN-8 1638956-60-1
Karavilagenin F Karavilagenin F 1639024-15-9
pan-HER-IN-2 化合物 PAN-HER-IN-2 1639040-95-1
UniPR129 化合物 T26310 1639159-47-9
Fluoroethylnormemantine hydrochloride FLUOROETHYLNORMEMANTINE HYDROCHLORIDE 1639210-25-5
CPL304110 化合物 CPL304110 1627826-19-0
Gü2602 化合物 Gü2602 1627094-88-5
hTYR/AbTYR-IN-1 HTYR/ABTYR抑制劑1 1625821-37-5
Azido-PEG3-C6-Cl 疊氮-三聚乙二醇-C6-氯 1625717-44-3
CT-2584 1H-Purine-2,6-dione, 1-[11-(dodecylamino)-10-hydroxyundecyl]-3,7-dihydro-3,7-dimethyl- 166981-13-1
(Rac)-Naxifylline NAXIFYLLINE異構體 166181-76-6
BrBzGCp2 S-4-bromobenzylglutathione cyclopentyl diester 166038-00-2
(Rac)-MEM 1003 3,5-Pyridinedicarboxylic acid, 4-(2-chloro-3-cyanophenyl)-1,4-dihydro-2,6-dimethyl-, 3-(2-methoxyethyl) 5-(1-methylethyl) ester 165187-25-7
ACT-660602 化合物 ACT-660602 1646267-59-5
RS1-PDK1 inhibitor N-(6-chloro-1,3-benzothiazol-2-yl)-1-benzothiophene-3-sulfonamide 1643958-85-3
Otilimab 對照抗體 1638332-55-4
MLK-IN-1 N-(3,4-二甲氧基苯基)-3-(7-甲氧基苯并[B]噻吩-2-基)咪唑并[1,2-B]噠嗪-6-胺 1627729-62-7
Delmetacin 地美辛 16401-80-2
Inotuzumab 英妥珠單抗 1660159-36-3
Copyright 2007? ChemicalBook. All rights reserved.